Clinical trials: Stage IV Chronic Lymphocytic Leukemia

Leukemia

Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia

• Completed
• Age: 18 to 75 years
• Phase 2
• Results posted

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.

Trial name

NCT00003659

Testing

filgrastim, rituximab, cyclophosphamide

Where

United States

Volunteers

39 people

Sponsor

Memorial Sloan Kettering Cancer Center